Mason Carrico

Stock Analyst at Stephens & Co.

(0)
# 4639
Out of 5,441 analysts
87
Total ratings
Success rate
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
NTRA Natera
Reiterates: Overweight
183 183
157.12 16.47% 5 Aug 15, 2025
VCEL Vericel
Reiterates: Overweight
67 67
35.45 89% 3 Jun 16, 2025
ILMN Illumina
Reiterates: Overweight
105 105
94.79 10.77% 8 May 20, 2025
PACB Pacific Biosciences
Reiterates: Overweight
2 2
1.25 44% 5 May 15, 2025
TXG 10x Genomics
Reiterates: Overweight
14 14
12.31 13.73% 6 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
77 70
68 2.94% 4 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
40 40
11.77 239.85% 10 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
140 115
86.99 32.2% 1 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
45 45
28.01 60.66% 6 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
4 4
3.2 25% 5 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
55 55
54.81 0.35% 5 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
4 2
1.29 39.53% 6 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
6 6
3.81 57.48% 2 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
17 17
27.29 -37.71% 2 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
52 52
33.61 54.72% 2 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
14 13
13.09 -0.69% 1 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
20 20
6.21 222.06% 4 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
41 41
19.13 114.32% 7 Jan 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
19 19
5.83 225.9% 1 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
2 2
n/a n/a 4 Apr 19, 2024